Close

Ratings by Nephron (Chris Pasquale)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/12/2022 Zimmer Biomet ZBH New Coverage Hold
(N/A)
103.30
(106.21)
2.82% Details
7/12/2022 ViewRay Inc. VRAY New Coverage Hold
(N/A)
2.82
(3.69)
30.85% Details
7/12/2022 Tandem Diabetes Care TNDM New Coverage Buy
(N/A)
56.73
(47.42)
-16.41% Details
7/12/2022 Stryker SYK New Coverage Buy
(N/A)
197.43
(206.93)
4.81% Details
7/12/2022 Procept BioRobotics Corp PRCT New Coverage Buy
(N/A)
30.97
(37.84)
22.18% Details
7/12/2022 Insulet Corporation PODD New Coverage Buy
(N/A)
230.82
(234.19)
1.46% Details
7/12/2022 Nevro Corp NVRO New Coverage Hold
(N/A)
46.60
(43.73)
-6.16% Details
7/12/2022 Inspire Medical Systems INSP New Coverage Buy
(N/A)
193.86
(171.59)
-11.49% Details
7/12/2022 Edwards Lifesciences EW New Coverage Buy
(N/A)
96.88
(84.74)
-12.53% Details
7/12/2022 DexCom DXCM New Coverage Buy
(N/A)
78.43
(80.66)
2.84% Details
7/12/2022 Cardiovascular Systems CSII New Coverage Hold
(N/A)
14.24
(12.93)
-9.2% Details
7/12/2022 Cooper Companies COO New Coverage Hold
(N/A)
304.56
(275.68)
-9.48% Details
7/12/2022 Boston Scientific BSX New Coverage Buy
(N/A)
37.51
(38.90)
3.71% Details
7/12/2022 Axonics Modulation Technologies Inc. AXNX New Coverage Buy
(N/A)
61.25
(65.24)
6.51% Details
7/12/2022 AxoGen, Inc. AXGN New Coverage Buy
(N/A)
8.14
(10.74)
31.94% Details
7/12/2022 Alcon Inc. ALC New Coverage Buy
(N/A)
70.62
(60.02)
-15.01% Details
7/12/2022 Abbott Labs ABT New Coverage Hold
(N/A)
108.89
(100.68)
-7.54% Details
7/12/2022 ABIOMED ABMD New Coverage Hold
(N/A)
262.07
(245.53)
-6.31% Details